Catalent, facing pressure from Elliott, had other activists in stock
By Svea Herbst-Bayliss NEW YORK (Reuters) – Contract drugmaker Catalent, which is being pushed to make changes to its board by Elliott Investment Management, had …
catalent
Activist investor Elliott takes stake in drug manufacturer Catalent – source
By Maggie Fick LONDON (Reuters) – Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent, a source familiar with the matter told …